These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6994350)

  • 1. [Therapeutic effectiveness of nevigramon in the complex treatment of acute dysentery].
    Gebesh VV; Koval'chuk VK; Ianushevskaia RI; Sofienko NIa; Lysak LI
    Vrach Delo; 1980 May; (5):110-3. PubMed ID: 6994350
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid.
    Fernandez LA
    J Kans Med Soc; 1966 Jul; 67(7):359-60 passim. PubMed ID: 5330682
    [No Abstract]   [Full Text] [Related]  

  • 3. Shigella isolation in Vellore, south India (1997-2001).
    Jesudason MV
    Indian J Med Res; 2002 Jan; 115():11-3. PubMed ID: 12424931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
    Panhotra BR; Saxena AK; Al-Mulhim K
    Jpn J Infect Dis; 2004 Jun; 57(3):116-8. PubMed ID: 15218222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
    Cheasty T; Day M; Threlfall EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation of dysentery drug therapy to the development of antibiotic resistance in Shigella].
    Kheĭlik AG; Man'kovskiĭ AV
    Antibiotiki; 1981 Aug; 26(8):606-7. PubMed ID: 7027914
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
    De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
    J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative effectiveness of the treatment of acute dysentery].
    Lyskovtsev MM; Myshkina OK; Romanova IG; Levicheva VS
    Klin Med (Mosk); 1979 Aug; 57(8):74-7. PubMed ID: 388065
    [No Abstract]   [Full Text] [Related]  

  • 9. [The adaptation of therapeutic standards as a function of antibiotic sensitivity of strains of Shigella spp. isolated in Rwanda in 1997].
    Aldighieri S; Kamoso P; Suermondt G; Rugimbanya P; Ngabonziza C; Kayirangwa E
    Med Trop (Mars); 1997; 57(4):412. PubMed ID: 9612786
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid.
    Vinh H; Wain J; Chinh MT; Tam CT; Trang PT; Nga D; Echeverria P; Diep TS; White NJ; Parry CM
    Trans R Soc Trop Med Hyg; 2000; 94(3):323-6. PubMed ID: 10975012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of biseptol in the overall treatment of acute sonne and flexner dysenteries].
    Gebesh VV; Vinogradova MD; Sofienko NI; Lysak LI
    Vrach Delo; 1978 Sep; (9):127-31. PubMed ID: 360614
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dispensary treatment of convalescents following acute dysentery].
    Tarasov VI; Voloshin AA
    Voen Med Zh; 1974 May; 5(0):46-8. PubMed ID: 4599744
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis and treatment of acute dysentery].
    Tarasov VI; Zinchuk NV; Dergacheva SI
    Voen Med Zh; 1977 Apr; (4):42-5. PubMed ID: 325896
    [No Abstract]   [Full Text] [Related]  

  • 14. Nalidixic acid for shigellosis.
    Parry HE
    Lancet; 1983 Nov; 2(8360):1206. PubMed ID: 6139566
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical aspects and treatment of dysentery].
    Ibragimov IM; Kurilo AV; Orekhova LL
    Voen Med Zh; 1977 Aug; (8):45-7. PubMed ID: 333732
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of an agent of 8-hydroxyquinoline group in treatment of acute dysentery].
    Gebesh VV; Sofienko NIa; Ianushevskaia RI; Lisak VI
    Vrach Delo; 1978 Mar; (3):143-7. PubMed ID: 148164
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current state of dysentery epidemiology (review of the literature)].
    Popovich GG; Bondarenko VI
    Vrach Delo; 1983 Jul; (7):94-9. PubMed ID: 6353765
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative analysis of the effect of polymyxin and monomycin on dysentery bacteria and enteropathogenic Coli bacteria in experiments and clinical cases].
    Khodalevich IV
    Antibiotiki; 1972 Mar; 17(3):222-4. PubMed ID: 4337880
    [No Abstract]   [Full Text] [Related]  

  • 19. [Outcomes of acute dysentery].
    Gebesh VV
    Vrach Delo; 1981 Sep; (9):116-9. PubMed ID: 7029905
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of R plasmids with a restrictive effect on phage-bacteria Shigella flexneri and Shigella sonnei systems.
    Rusu V; dorobăţ O; Meitert T; Pencu E; Lăzăroaie D
    Arch Roum Pathol Exp Microbiol; 1980; 39(2):113-20. PubMed ID: 6998412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.